Hepatitis e virus infection: Multiple faces of an underestimated problem

Journal of Hepatology

Volumn 58, Issue 5, 2013, Pages 1045-1046

  Pischke, Sven ^a   Wedemeyer, Heiner ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HEPATITIS E ANTIBODY; MYCOPHENOLIC ACID; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

ANTIBODY DETECTION; ANTIVIRAL THERAPY; BLOOD ANALYSIS; DISEASE COURSE; FECES ANALYSIS; FOOD CONTAMINATION; GENOTYPE; GERMANY; GLOMERULONEPHRITIS; GUILLAIN BARRE SYNDROME; HEPATITIS E; HUMAN; INFECTION RATE; LIVER CIRRHOSIS; MONOTHERAPY; MORTALITY; NONHUMAN; NOTE; PRIORITY JOURNAL; RNA ANALYSIS; TREATMENT DURATION; VIRAL CONTAMINATION; VIRUS TRANSMISSION; WATER CONTAMINATION;

ANTIVIRAL AGENTS; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; PREVALENCE; VIRAL VACCINES; WORLD HEALTH;

EID: 84876288556     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.12.013     Document Type: Note

References (10)

1. Wedemeyer H, Pischke S, Manns MP. Pathogenesis and Treatment of Hepatitis E Virus Infection. Gastroenterology 2012;142:1388-1397 e1381.
2. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, et al. Hepatitis E. Lancet 2012;379:2477-2488.
3. Baylis SA, Koc O, Nick S, Blmel J. Widespread distribution of hepatitis E virus in plasma fractionation pools. Vox Sang 2011;102:182-183.
4. Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, Krüger DH, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol 2012;56:500-502.
5. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010;376:895-902.
6. Bose PD, Das BC, Kumar A, Gondal R, Kumar D, Kar P, et al. High viral load and deregulation of the progesterone receptor signaling pathway: Association with Hepatitis E-related poor pregnancy outcome. J Hepatol 2011;54:1107-1113.
7. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012;55:988-997.
8. Suneetha PV, Pischke S, Schlaphoff V, Grabowski J, Fytili P, Gronert A, et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 2012;55:695-708.
9. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, et al. Factors associated with chronic hepatitis in patients with hepatitis e virus infection who have received solid organ transplants. Gastroenterology 2011;140:1481-1489.
10. Pischke S, Stiefel P, Franz B, Bremer B, Suneetha PV, Heim A, et al. Chronic hepatitis E in heart transplant recipients. Am J Transplant 2012;12:3128-3133